surfactants

Evonik has reorganized its strategic research activities into the Evonik Innovation Factory, an entrepreneurial unit tasked with advancing selected technologies from laboratory development toward industrial production within an average five‑year program cycle. The unit’s stated technical priorities—rhamnolipid biosurfactants, a portfolio of biopolymers, and anion exchange membranes—may have implications for manufacturing scale‑up, intellectual property strategy, and regulatory compliance in chemical manufacturing contexts.